Get the Daily Brief
Latest Biotech News
Patient-Centric Focus Drives Biotech Innovation at BIO 2025 Convention
At the 2025 BIO International Convention, industry leaders reiterated the centrality of patients to biotechnology innovation. Panels highlighted the vital role of patient advocacy, including...
New Scheduling Model Enhances Neonatal Intensive Care Efficiency and Staff Wellbeing
A cutting-edge hours-based scheduling system tailored for neonatal intensive care units (NICUs) has been developed to improve patient outcomes and provider wellbeing. Departing from traditional...
Critical Gaps in Environmental Chemical Monitoring Threaten Aquatic Ecosystem Safety
Recent investigations reveal substantial shortcomings in chemical monitoring programs, with under 1% of the estimated 300,000 chemicals of environmental concern regularly assessed in U.S. surface...
Zealand Pharma’s Dual GLP-1/GLP-2 Agonist Demonstrates Robust Weight Loss in Phase 1b
Zealand Pharma reported updated phase 1b results for its dapiglutide, a dual glucagon-like peptide-1 and peptide-2 receptor agonist, showing an average body weight reduction of 11.6% after 28...
Scholar Rock’s Myostatin Blocker Preserves Lean Mass with Obesity Treatment
In a Phase 2 study, Scholar Rock’s apitegromab, an anti-myostatin antibody, was shown to preserve lean muscle mass in patients undergoing weight loss therapy with Eli Lilly’s Zepbound...
FDA Overhauls Drug Review Process Amid Leadership Changes
The U.S. Food and Drug Administration (FDA) is undergoing significant shifts in leadership and procedural reforms aimed at accelerating drug approval timelines. Key cell and gene therapy leaders...
Gilead’s Twice-Yearly HIV Prevention Shot Gains FDA Approval
The FDA approved Gilead Sciences’ lenacapavir (commercially Yeztugo), a long-acting injectable pre-exposure prophylaxis (PrEP) treatment against HIV that requires just two injections annually....
Lilly’s $1.3B Bet on Gene Therapies for Cardiovascular Disease
Eli Lilly advanced its gene therapy pipeline with a $1.3 billion acquisition of CRISPR startup Verve Therapeutics, adding VERVE-102, an in vivo CRISPR base editor targeting PCSK9 for...
Financial Strain Widens Among Biotech Firms: EY Reports
The latest EY Biotech Beyond Borders report reveals that nearly 40% of biotech companies face cash runways shorter than 12 months — the highest level in over six years. This alarming trend...
Artificial Cells Production Breakthrough Using Microfluidics
Researchers led by Professor Hiroaki Suzuki at Chuo University have pioneered a microfluidic-based technology for mass-producing uniform artificial cells containing DNA condensates simulating...
Zealand Pharma’s GLP-1/GLP-2 Dual Agonist Shows Promising Weight Loss Results
Zealand Pharma reported updated phase 1b trial data for its dual GLP-1/GLP-2 receptor agonist dapiglutide, with patients on higher dosing regimens experiencing mean body weight reductions of 11.6%...
Qiagen Launches Digital PCR Partnering Program for Oncology Assays
Qiagen has initiated a third-party partnering program to expand its clinical digital PCR platform's test menu, signing South Korea-based Gencurix Oncology as the inaugural partner. The...
Advances in Single-Cell and Spatial Omics Illuminate PTSD Mechanisms
Cutting-edge single-cell transcriptomic and epigenomic analyses have elucidated molecular and cellular alterations underpinning post-traumatic stress disorder (PTSD). Studies have identified...
Biofilm-Resistant Surface Patterns Combat Medical Device Infections
Researchers at the University of Nottingham have developed innovative microtopographical patterns on plastic surfaces that drastically inhibit bacterial adhesion and biofilm formation, a leading...
AI Integration Enhances Genomic Variant Interpretation in Cancer Diagnostics
A strategic partnership between Intelliseq and Genomenon integrates the Cancer Knowledgebase (CKB) somatic variant data into Intelliseq’s iFlow platform, improving clinical interpretation of tumor...
FDA launches pilot program to accelerate drug reviews for national priorities
FDA Commissioner Martin Makary introduced a pilot Commissioner’s National Priority Voucher program aimed at drastically reducing drug review times for products meeting defined U.S. national...
Gilead secures FDA approval for twice-yearly HIV prevention shot
The FDA approved Gilead Sciences’ lenacapavir (Yeztugo) as a revolutionary pre-exposure prophylaxis (PrEP) option for HIV prevention, requiring only two injections annually. The approval follows...
Emerging antibody therapies advance in oncology and autoimmune diseases
Recent clinical developments highlight novel antibody-based therapeutics showing promise across cancer and autoimmune disorders. Aptevo Therapeutics’ mipletamig updated data reveal an 85%...
Breakthroughs in cancer genomics and precision diagnostics
Several institutions report advances in cancer genomic profiling and diagnostics. Caris Life Sciences completed a $494 million IPO highlighting their AI-driven multimodal clinico-genomic platform...
Innovations in AI and machine learning for drug discovery and healthcare
Artificial intelligence applications continue to transform biotech and healthcare sectors. Nutcracker Therapeutics develops open-source RNA manufacturing platforms optimized for personalized mRNA...